Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00234429
Status:
COMPLETED
Last Update Posted:
2007-12-18
First Post:
2005-10-05
Brief Title:
A Phase 2 Study of Tomudex Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Colorectal Cancer |
Keywords:
| Name | View |
|---|---|
| Colorectal carcinoma advanced disease | View |